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Background: Campylobacteriosis caused by Campylobacter spp. is the most common notifiable bacterial
gastrointestinal disease in Germany and a major problem in many other European countries as well. In contrast to
other infectious diseases, e.g., salmonellosis, the annual number of notified campylobacteriosis cases has increased
in Germany and other European countries from 2001–2010.
Methods: National surveillance data from 2001 through 2010 were the basis of a detailed description of the
epidemiological pattern of Campylobacter infections in Germany. Special focus was placed on geographical
distribution and time trends of Campylobacter infections as well as the identification of risk groups.
Results: In total, 588,308 cases of campylobacteriosis were recorded during the observed time period. The mean
annual incidence increased from 67 cases/100,000 population in 2001 to 80/100,000 population in 2010. Almost
92% of the notified Campylobacter infections were acquired in Germany. A seasonal distribution was observed with
a large peak in the summer months and a small peak in January. Incidence was highest in children ≤4 years and
young adults 20–29 years of age. Especially young children living in rural regions in Germany seemed to be at high
risk of Campylobacter infection.
Conclusions: Campylobacter is the leading cause of bacterial gastroenteritis in Germany, and has been of rising
public health concern. There is a need for enhanced prevention of Campylobacter infections and the data
presented here may contribute to better target prevention measures with focus on identified risk groups such as
children and young adults.
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Campylobacteriosis is the most frequently reported
zoonosis in the European Union (EU) and the most
common notified bacterial gastrointestinal disease in
Germany [1]. In contrast to other infectious diseases,
e.g., salmonellosis, the annual number of notified cam-
pylobacteriosis cases has increased in many European
countries in recent years [1]. In the United States,
Campylobacter infection is the second most common
cause of bacterial enteritis after salmonellosis, with 2.4
million cases estimated to occur per year [2,3]. Thus, the
burden of gastrointestinal disease due to Campylobacter
is substantial.* Correspondence: SchielkeA@rki.de
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reproduction in any medium, provided the orSeveral Campylobacter species are known to be patho-
genic to humans [4], with Campylobacter jejuni being the
leading cause of campylobacteriosis worldwide, followed
by C. coli [5]. Campylobacter can be transmitted human-
to-human by the faecal-oral route. However, zoonotic or
foodborne transmission predominates and Campylobacter
is held responsible for a considerable part of foodborne
infections [6].
The bacteria are widespread in the environment and
have been detected in various animal reservoirs, for
example, poultry, cattle, swine, and dogs [5]. Prevalence of
Campylobacter is particularly high in chickens; therefore,
contact to chickens and consumption of chicken meat are
regarded as important risk factors for campylobacteriosis
[5,7,8]. Although Campylobacter requires special growth
conditions and is not able to multiply in an aerobic
atmosphere, the bacteria may survive on food or in thel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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infective dose for humans is very low [11].
The incubation period typically varies from one to
seven days before diarrhoea, abdominal cramps and fever
may occur as the most common symptoms [4]. The disease
is self-limiting and symptoms typically disappear within
one to three weeks. Reactive arthritis and the Guillain–
Barré syndrome are rarely observed sequelae of a Cam-
pylobacter infection [12].
The aim of this report is to describe demographic and
geographic determinants and trends of campylobacteriosis
in Germany from 2001 through 2010 in order to identify
possible starting points for appropriate countermeasures
and to provide a basis for disease management decisions.Methods
According to the Protection against Infection Act that has
been in effect in Germany since 2001, direct or indirect
detection of enteropathogenic Campylobacter is notifiable,
if indicating an acute infection in humans. Primary diag-
nostic laboratories are obligated to inform the responsible
local health department in the district where the patient
resides. Anonymised notification data are electronically
forwarded by the local health department via the state
health department to the Robert Koch Institute (RKI),
the federal public health institute.
We analysed the national surveillance data on notified
Campylobacter infections from 2001 through 2010. Only
cases fulfilling the reference definition were included in
data analysis, which comprises cases with at least one
clinical symptom of campylobacteriosis (diarrhoea, abdom-
inal pain, fever) and with either a laboratory confirmed
Campylobacter infection or an epidemiological con-
firmation, which includes a link to a laboratory-confirmed
case or to a contaminated food item.
Routine surveillance data include information on age,
sex, district of place of residence, date of disease onset,
country/district of exposure, hospitalisation (admittance
to hospital) and the detected Campylobacter species. We
counted only hospitalisations with a disease onset before
the hospitalisation date so that solely hospitalisations
due to a campylobacteriosis were included in the analysis.
These data are available through the national level data-
base (SurvNet) at the RKI. Data are publically accessible
via SurvStat@RKI (http://www3.rki.de/SurvStat/). Popula-
tion data provided by the Federal Statistical Office have
been used for calculation of campylobacteriosis incidence.
Urban and rural regions were classified according to the
criteria proposed by the Federal Institute for Research
on Building, Urban Affairs and Spatial Development
(German: Bundesinstitut für Bau-, Stadt- undRaumforschung
[BBSR]). Cities with more than 100,000 inhabitants and
districts with more than 150 inhabitants per km2 weredefined as urban. Accordingly, cities with less than
100,000 inhabitants and districts with less than 150
inhabitants per km2 were classified as rural [13]. A variable
termed “geographic setting” was formed with the two
categories urban and rural.
Data analysis was conducted with Microsoft Excel 2010,
and geographic maps were prepared with Regiograph
version 11 (GfK GeoMarketing GmbH, Bruchsal, Germany).
Statistical calculations were performed with Stata 12 (Stata
Corporation, College Station, TX; USA). Poisson regression
analysis with offset equal to the population size was
conducted to estimate incidence and associated 95%
confidence intervals (CI) and for group comparisons.
P values <0.05 were considered statistically significant.Results
Demographic distribution
From 2001 through 2010, a total of 588,308 cases fulfilling
the reference definition were recorded in Germany. Most
of these cases occurred sporadically (97%) with only a
small proportion of cases reported in relation to out-
breaks. The mean annual incidence was 72 cases/100,000
population ranging from 58/100,000 in 2003 to 81/
100,000 in 2007. Mean incidence was slightly higher for
men (96/100,000 population) than women (83/100,000
population) with an incidence rate ratio (IRR) of 1.15,
P < 0.001. Incidence was highest in children 0–4 years
of age compared to all other age groups (123/100,000 and
69/100,000 population, respectively, P < 0.001), particularly
in one-year-old boys (205/100,000 population). A high
incidence also occurred in young adults 20–29 years of
age compared to all other age groups (107/100,000 and
67/100,000 population, respectively, P < 0.001). In contrast
to other age groups, among the 20-29-year-olds, women
were more frequently affected than men (113/100,000
and 101/100,000 population, respectively, P < 0.001) (see
Figure 1). The majority of notified Campylobacter infections
was acquired in Germany. Only 8% of cases were reported
as travel-related. The most frequently named countries
of infection were Spain, Turkey, France, Italy and India.
The proportion of travel-related cases was highest
in persons 25–39 years of age (11%) and lowest in
persons ≥70 years of age (3%).Seasonal distribution
For Campylobacter infections a marked seasonality was
observed. Incidence increased strongly from May to July
and peaked in August with a monthly incidence of about
9/100,000 population (see Figure 2). The high incidence
of infections in the summer months was independent
of the year of notification and the age group and was
observed for urban as well as rural regions. Interestingly,
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Figure 1 Incidence of campylobacteriosis in Germany by age group and sex, 2001–2010. Note that age group ranges vary.
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http://www.biomedcentral.com/1471-2334/14/30notified Campylobacter infections with disease onset
in the first days of January was recognizable in all age
groups in most years in urban as well as rural regions.
The proportion of travel-related infections was highest in










































Figure 2 Seasonal distribution of reported campylobacteriosis in GermGeographic distribution
The incidence of notified Campylobacter infections was
higher in the eastern German federal states (Berlin,
Brandenburg, Mecklenburg-Western Pomerania, Saxony,
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German federal states, the incidence in one-year-old
children was more than threefold higher (414/100,000
population) compared with the incidence in this age
group in western German federal states (138/100,000
population) (P < 0.001). Additionally, in eastern Germany,
the incidence in one-year-old children was about
threefold higher than the incidence in young adults
20–24 years of age, whereas in western Germany, the
incidences in these two age groups were similar (see
Figure 4).Figure 3 Geographic distribution of reported campylobacteriosis in GerUrban–rural differences
The incidence in rural regions was 69/100,000 population
and in urban areas 73/100,000 population (P < 0.001).
Seasonality with high incidence in the summer months
was observed in both settings. Children living in rural
regions in Germany were more frequently affected by
Campylobacter infections than children living in urban re-
gions, which is especially obvious in the age group <10 years
of age (130/100,000 and 83/100,000; P < 0.001). Vice versa,
for higher age groups, incidences were higher in persons
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Figure 4 Incidence of campylobacteriosis in Germany by age and geographic setting, 2001–2010. Note that age group ranges vary.
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living in a rural or an urban setting were 64/100,000 and
77/100,000, respectively (P < 0.001) (see Figure 4).
Campylobacter species and diagnostics
For 67% of the notifications a Campylobacter species
was reported. Of those, 90% were caused by C. jejuni,
about 7% by C. coli, and about 2% by other Campylobacter
species, with C. lari, C. fetus and C. upsaliensis being
the most frequently reported other species. For 33% of
notified Campylobacter infections, differentiation between
the species C. jejuni and C. coli had not been performed,
or the species had not been typed at all, or was not
reported. In rural as well as urban regions, C. jejuni was
the main cause of campylobacteriosis. Increased incidence
in the summer months was observed for both C. jejuni
and C. coli, independent of the geographic setting. Cultiva-
tion is the “gold standard” for detection of Campylobacter
and 86% of notified cases were diagnosed on the basis of
this method. Enzyme immunoassays (EIA) were used for
diagnosis in about 9% of notified cases. A combination of
different detection methods was conducted in about 3% of
notified cases, primarily cultivation in combination with
EIA. In about 2% of notified cases the diagnostic method
was not reported.Hospitalisation
On average, 10% of campylobacteriosis cases were reported
as having been hospitalised because of the disease, which
would correspond to a total number of 58,000 cases.
Hospitalisation was more common among children <1 year
of age (14% of cases) and elderly persons ≥70 years of age
(22% of cases).
Time trends
Overall, the annual incidence has increased significantly
since 2001 (P < 0.001) resulting in more than 65,000 re-
ported infections in 2010. This corresponds to an incidence
of 80/100,000 population. Merely in 2003, 2006, and 2009
incidence was lower than in the respective previous year
(see Figure 5). The strongest increase in the number of
notified cases in the observed time period was recognized
in the age group ≥15 years, especially in persons ≥50 years
of age where the incidence increased from 39/100,000
population in 2001 to 61/100,000 population in 2010. In
contrast, the incidence among children <10 years of age
decreased in the same time period from 106/100,000 to
83/100,000. The proportion of hospitalisations increased
from 9% in 2001 to 15% in 2010 (P < 0.001). The propor-
tion of imported infections decreased from 11% in 2001 to













































Figure 5 Annual incidence of campylobacteriosis in Germany, 2001–2010.
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German surveillance data on campylobacteriosis were
analysed for a ten-year period from 2001 through 2010.
The incidence of Campylobacter infections in Germany
was high with a mean annual incidence of 72/100,000
population. The overall increase over the observed
time period was mainly due to a rise of domestically
acquired cases.
The disease burden of bacterial enteritis due to Cam-
pylobacter is substantial in many European countries.
In he EU, campylobacteriosis is the most commonly
reported zoonosis with C. jejuni accounting for most
of the confirmed cases [1,2]. An upward trend of the
incidence of Campylobacter infections in the EU has been
observed since 2005. The incidence in Germany exceeds
the European average incidence of Campylobacter infec-
tions (80/100,000 vs. 49/100,000 in 2010). However, the
incidence of campylobacteriosis varies widely among
the reporting EU countries, most likely due to different
surveillance and health care systems. Also, differences
in Campylobacter related risk factors, e.g. diet patterns,
contamination levels of different food items, or climatic
factors, may play a role [14]. Sero-epidemiological studies
indicate that under-ascertainment of Campylobacter infec-
tions is likely [15-17]. Analysis of routine surveillance data
is mainly limited by under-ascertainment and under-
reporting. Notified cases may not be representative of
all Campylobacter infections in the population because
diseased persons, especially those with mild infections,
do not necessarily seek medical care and, in addition
physicians do not always order stool analysis from
patients with diarrheal diseases. Both are prerequisitesfor notification. Furthermore, diagnosed infections may
not always be reported to the health authorities despite
being mandatory by law.
Campylobacteriosis is assumed to be mainly a food-borne
disease and the consumption of poultry is one major risk
factor [5,7,8]. In contrast to the consumption of pork
or beef, the annual consumption of poultry increased
from 1996 to 2006 in Germany (from 8.4 to 9.9 kg per
capita) [18]. This may partly explain the increase in the
incidence of Campylobacter infections in Germany, as
poultry is frequently contaminated with Campylobacter.
Routine monitoring of zoonotic pathogens in food and
farmed animals in Germany revealed that the prevalence
of Campylobacter in poultry meat ranged from 14% to
34% per year. In contrast, contamination of beef and
pork with Campylobacter was markedly lower [1,19].
The prevalence of Campylobacter in chickens ranged
from 6% to 64% per year [1,19]. However, a distinct trend
in the annual prevalence of Campylobacter in poulty
meat and in chickens was not observed for the years
2001–2010. In contrast to Campylobacter infections, the
number of human infections due to Salmonella enterica
serovar Enteritidis has decreased in recent years, which
is mainly attributed to successful Salmonella control
programmes in poultry including immunisation [1,19].
To date, programmes to control Campylobacter in
poultry have not been implemented successfully.
In Germany, incidence of campylobacteriosis was particu-
larly high in the years 2002, 2005 and 2007. Several expla-
nations are possible. The low number of Campylobacter
cases reported in 2001 may reflect an artefact of reporting
because the Protection against Infection Act was newly
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in its infancy. In 2002, the surveillance system was fully
established resulting in a higher number of notified cases.
In 2004, diagnostic criteria for the campylobacteriosis case
definition for notifications were modified to include EIA
and enzyme-linked immunosorbent assays (ELISA) [20].
Using these antigenic tests, non-culturable bacteria can
be detected as well. Thus, the enhanced use of these
test systems most likely resulted in the strong increase
in notified cases in 2005. Various possible reasons have
been discussed for the elevated case numbers in 2007
[20]. For instance, the prevalence of Campylobacter in
routinely tested chickens and chicken herds was higher
in 2007 and the prevalence of Campylobacter in poultry
and chicken meat was increased in this year compared
to previous years [21]. Furthermore, warm weather in the
spring of 2007 may have triggered recreational activities
with enhanced exposure to possible risk factors, for ex-
ample consumption of undercooked meat at barbecues
[8], or swimming in contaminated water bodies [7].
A correlation between temperature and number of
campylobacteriosis cases has been described before and
may also explain the seasonal pattern of the disease with
an incidence peak in the summer months, which has
been described for many countries [22,23]. In Germany,
Campylobacter incidence peaks both in rural as well as
urban areas in the summer. Such a seasonal pattern is
also characteristic for other zoonotic enteric diseases of
bacterial origin, e.g., salmonellosis, indicating similar
transmission routes [1,22]. Contamination of broilers and
chicken meat with Campylobacter tends to be higher in the
summer months. The contamination rate of Campylobacter
in broilers was found to be highest in August [24]. Chicken
legs at retail examined during a one-year study in Germany
showed two peaks of contamination, one from February to
March and the second from July to August [25].
Interestingly, in addition to the incidence peak in the
summer months, we observed a second, smaller incidence
peak of campylobacteriosis in January. This peak was not
due to a reporting delay over the Christmas and New
Year’s holidays but was caused by an increase of infections
with disease onset in the early days of January, which may
indicate exposure of patients to Campylobacter-contami-
nated food items at the end of the previous year, possibly
on New Year’s eve. Further studies would have to be
conducted to elucidate this incidence increase.
In Germany as well as in the EU, incidence was highest
among children under four years of age and, in particular,
one-year-old boys were affected. This is in line with the
epidemiology of other gastrointestinal infectious diseases
showing a comparable demographic pattern, e.g., infections
with Yersinia enterocolitica, Salmonella spp., and Shiga
toxin-producing Escherichia coli (STEC) with peak inci-
dence in young children [26-28]. The immune response ininfants has not fully established, which may explain
their susceptibility to various infectious diseases. However,
other age-specific risk factors, like e.g. insufficient hand
hygiene or close contact to animals or to the environment,
may also play a role.
A high incidence of campylobacteriosis was also found
in adults aged 20–29 years in Germany. Interestingly,
women were more frequently affected than men in this
age group in contrast to all other age groups, in which
men were more frequently infected. This age and gender
distribution has also been reported for other countries
(England, Wales, and the Netherlands) [15,29]. Possible
reasons may be a higher risk of exposure in women of
this age group due to human-to-human transmission
from young children they take care of or because they
prepare and eat chicken more frequently than men of
this age group, possibly resulting in Campylobacter
infections if food items are not sufficiently heated or
cross-contaminated.
The German surveillance data show that children
living in rural regions were more frequently affected
by Campylobacter infections than children living in
urban areas. In contrast, this effect was not observed
or even reversed in older persons (Figure 4). Our result is
consistent with a study conducted in the German federal
state of Hesse from 2005–2006 [30] that examined the
association between age-specific Campylobacter incidence
and the degree of urbanicity of the district of the place of
residence also showing an increased incidence in children
living in rural areas. This has also been demonstrated
by other studies in Europe [23,31]. It is conceivable that
children in rural areas may be more exposed to farm
animals, including chickens, and to other possible sources
of Campylobacter (e.g., contaminated water, wild birds)
than children living in urban areas [8].
Conclusions
Surveillance of notifiable diseases provides valuable data
on demographic and geographic determinants as well
as trends of campylobacteriosis in Germany. Children
and young adults, and particularly children living in
rural regions, were identified as groups at high risk of
Campylobacter infection. Efforts should be undertaken
to control campylobacteriosis and reduce infection risks
particularly in these risk groups. Prevention measures
should include strengthening efforts to reduce Cam-
pylobacter prevalence in farm animals and food as well
as providing detailed information on the risks of Cam-
pylobacter infection to the target groups. We were able
to identify vulnerable population groups in our analysis.
However, the associated risk factors are not known in
detail. Thus, the investigation of age-specific and season-
related as well as geographic setting-related risk factors
should be the focus of further research.
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